- Home
- EIG vs BCRX Comparison
EIG vs BCRX Comparison
Compare EIG & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIG
- BCRX
- Stock Information
- Founded
- EIG 2000
- BCRX 1986
- Country
- EIG United States
- BCRX United States
- Employees
- EIG N/A
- BCRX N/A
- Industry
- EIG Property-Casualty Insurers
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EIG Finance
- BCRX Health Care
- Exchange
- EIG Nasdaq
- BCRX Nasdaq
- Market Cap
- EIG 1.3B
- BCRX 1.6B
- IPO Year
- EIG 2007
- BCRX 1994
- Fundamental
- Price
- EIG $50.02
- BCRX $7.70
- Analyst Decision
- EIG Strong Buy
- BCRX Strong Buy
- Analyst Count
- EIG 1
- BCRX 5
- Target Price
- EIG $58.00
- BCRX $15.60
- AVG Volume (30 Days)
- EIG 139.9K
- BCRX 1.9M
- Earning Date
- EIG 02-13-2025
- BCRX 02-24-2025
- Dividend Yield
- EIG 2.40%
- BCRX N/A
- EPS Growth
- EIG 20.58
- BCRX N/A
- EPS
- EIG 5.34
- BCRX N/A
- Revenue
- EIG $889,800,000.00
- BCRX $412,579,000.00
- Revenue This Year
- EIG N/A
- BCRX $38.01
- Revenue Next Year
- EIG $1.18
- BCRX $19.04
- P/E Ratio
- EIG $9.36
- BCRX N/A
- Revenue Growth
- EIG 5.05
- BCRX 29.92
- 52 Week Low
- EIG $38.38
- BCRX $4.03
- 52 Week High
- EIG $54.44
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- EIG 37.65
- BCRX 52.40
- Support Level
- EIG $50.34
- BCRX $7.46
- Resistance Level
- EIG $51.30
- BCRX $8.10
- Average True Range (ATR)
- EIG 0.85
- BCRX 0.32
- MACD
- EIG -0.18
- BCRX 0.02
- Stochastic Oscillator
- EIG 3.67
- BCRX 57.89
About EIG Employers Holdings Inc
Employers Holdings Inc provides workers' compensation insurance, to small businesses in low- to medium-hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through itswholly owned subsidiaries.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.